SCHEMBL14088018

SCHEMBL14088018

Cc1c(-c2ccc3[nH]ccc3c2)c(=O)oc2c3c4c(cc12)CCCN4CCC3

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.45
▸ KMT2A Q03164 7/20 0.45
▸ ALDH1A1 P00352 6/20 0.45
▸ USP2 O75604 5/20 0.45
▸ MAPT P10636 5/20 0.45
▸ KDM4E B2RXH2 4/20 0.45
▸ LMNA P02545 4/20 0.45
▸ GAA P10253 4/20 0.45
▸ HPGD P15428 4/20 0.45
▸ CASP1 P29466 3/20 0.45
▸ CASP7 P55210 3/20 0.45
▸ HSD17B10 Q99714 3/20 0.45
▸ GLA P06280 2/20 0.45
▸ ATM Q13315 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ TDP1 Q9NUW8 3/20 0.44
▸ RECQL P46063 3/20 0.44
▸ TLR9 Q9NR96 1/20 0.44
▸ MCL1 Q07820 1/20 0.44
▸ SLC16A3 O15427 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14088005 0.87 MEN1 (0.51) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL14088001 0.82 USP2 (0.58) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL17716546 0.79 ALDH1A1 (0.48) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL17914323 0.78 ALDH1A1 (0.62) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL17716547 0.78 MEN1 (0.47) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL17716545 0.76 USP2 (0.46) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL14087996 0.76 ALDH1A1 (0.44) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL17716529 0.76 MCL1 (0.46) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL14088016 0.75 ALDH1A1 (0.43) MEN1KMT2AALDH1A1USP2MAPT
SCHEMBL17716528 0.75 MEN1 (0.45) MEN1KMT2AALDH1A1USP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT MEN1 1950/4885KMT2A 1156/4885ALDH1A1 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback